Carvedilol Phosphate Capsule, Extended Release
Product Images NDC 51407-051

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol Phosphate (NDC 51407-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407 050 30ol

This is a description of Carvedilol Extended-Release capsules in the strength of 10 mg, packaged in a container of 30 capsules. The dosage information is available in the package insert. The capsules must be stored at a temperature between 20°C to 25°C. These capsules are different from carvedilol tablets. Caution must be taken to keep them out of reach of children and dispensed in a light-resistant container. These capsules are manufactured by Frontida Blopharm, Inc., Philadelphia, PA, and packaged by GSMS, Incorporated, Camarillo, CA.*

FDA Label Image

51407 051 30ol

This is a medication in the form of an extended-release capsule, containing 20 mg of Carvedilol Phosphate. The package contains 30 capsules, and dosage information can be found in the package insert. The medication should be stored at 20-25°C (68-77°F). Each capsule is manufactured by Frontida Blopharm and packaged by GSMS.*

FDA Label Image

51407 052 30ol

This is a medication package of 30 capsules of Carvedilol Phosphate at a strength of 40mg each. The medication is identified by the NDC numbers 51407-052 and 5140705230. The extended-release capsule is different in strength from Carvedilol tablets. Dosage information can be found in the package insert. The medication should be stored at 20° to 25°C (68° to 77°F). The medication must be kept out of the reach of children and dispensed in a tight, light-resistant container. The package was manufactured by Frontida Biopharm, Inc. in Philadelphia, PA 19124, and packaged by GSMS, Incorporated in Camarillo, CA 93012 USA.*

FDA Label Image

51407 053 30ol

This is a medication in the form of extended-release capsules for once-a-day dosing. The name of the medication is Carvedilol Phosphate and it is produced by GSMS Incorporated. The NDC code for the medication is 51407-053-30. The text also includes instructions to store the medication at a controlled room temperature.*

FDA Label Image

Structure (Carvedilol 1)

FDA Label Image

Figure 5 (Carvedilol 2)

Change in SBP and DBP readings are presented in the given text. The data is graphically represented, with the x-axis indicating the time after the morning dose in hours, and the y-axis indicating the change in blood pressure in mmHg. The lines are smoothed using a locally weighted regression smoothing methodology. No further information or context is available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.